Abstract
Clinical, pathological feature and steroid hormone receptors (SR) including receptors of estrogen (ER), progesterone (PR) and androgen (AR) were observed in 58 cases of breast carcinoma, and related to patient 5-year survival rate through stratification and multivariate analysis. The results showed that histologic tumor type and grading, lymphnode status, ER value and patient age took more important role in patient survival, and SR, especially, conferred survival advantage in advanced cases with tumor size larger than 2 cm, node involved, or TNM Stage II–III.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
1984; 19:291.
1989; 18:247.
1984;4:18.
Berger U, et al. Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features on primary breast cancer. Hum Pathol 1987; 18: 1263.
Williams MR, et al. Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 cases. Br J Cancer 1987; 55:67.
Vollenweider-Zerargui L, et al. The predictive value of estrogen and progesterone receptors’ concentrations on the clinical correlation on 547 pauents. Cancer 1986; 57:1171.
1990; 19:264.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, Q., Rao, H., Wang, B. et al. Correlation of steroid hormone receptors and clinical pathological features with prognosis of human breast cancer. Chin J Cancer Res 3, 58–63 (1991). https://doi.org/10.1007/BF02997280
Issue Date:
DOI: https://doi.org/10.1007/BF02997280